Affiliations 

  • 1 Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, UK. ms30@sanger.ac.uk
  • 2 Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, UK
  • 3 Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, UK. cts@sanger.ac.uk
Genome Biol, 2018 Jan 17;19(1):5.
PMID: 29343290 DOI: 10.1186/s13059-017-1380-2

Abstract

We present a new method, Fine-Mapping of Adaptive Variation (FineMAV), which combines population differentiation, derived allele frequency, and molecular functionality to prioritize positively selected candidate variants for functional follow-up. We calibrate and test FineMAV using eight experimentally validated "gold standard" positively selected variants and simulations. FineMAV has good sensitivity and a low false discovery rate. Applying FineMAV to the 1000 Genomes Project Phase 3 SNP dataset, we report many novel selected variants, including ones in TGM3 and PRSS53 associated with hair phenotypes that we validate using available independent data. FineMAV is widely applicable to sequence data from both human and other species.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.